Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;90(3):635-637.
doi: 10.1016/j.jaad.2023.08.112. Epub 2023 Nov 4.

Preliminary summary and reclassification of cases from the Pediatric Research of Management in Stevens-Johnson syndrome and Epidermonecrolysis (PROMISE) study: A North American, multisite retrospective cohort

Sylvia Martinez-Cabriales  1 , Jerome Coulombe  2 , Michelle Aaron  3 , Sadaf H Hussain  4 , Danny Linggonegoro  4 , Irene Lara-Corrales  5 , Hailey Barootes  5 , Heather Brandling-Bennett  6 , Isabela Covelli  6 , Anna Yasmine Kirkorian  7 , Nidhi Shah  7 , Leslie Castelo-Soccio  8 , Paige McKenzie  8 , Lisa M Arkin  9 , Adam Heinze  9 , Carmen Liy-Wong  10 , Nicole Travis  10 , Michael Rieder  11 , Blanca R Del Pozzo-Magana  11 , Jennifer J Schoch  12 , Reesa Monir  12 , Sharon A Glick  13 , Laura Uwakwe  13 , Sarah Skillman  14 , Dan P Hekman  14 , Brendan C Lethebe  15 , Michele L Ramien  16
Affiliations

Preliminary summary and reclassification of cases from the Pediatric Research of Management in Stevens-Johnson syndrome and Epidermonecrolysis (PROMISE) study: A North American, multisite retrospective cohort

Sylvia Martinez-Cabriales et al. J Am Acad Dermatol. 2024 Mar.
No abstract available

Keywords: DEN; RIME; Stevens-Johnson syndrome; TEN; drug epidermal necrolysis; pediatric dermatology; reactive infectious mucocutaneous eruption; toxic epidermal necrolysis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Dr Lara-Corrales has received honoraria from Pierre Fabre, Amgen, Ipsen, Novartis, Pfizer, and Sanofi Genzyme and grants from AbbVie, Janssen, Clementia, Eli Lilly, Mayne Pharma, and Sanofi Genzyme. Dr Liy-Wong is advisor for Sanofi, Bayer, and Pfizer. Dr McKenzie is advisor for AbbVie, Amgen, Bausch, Bristol-Myers, Celgene, Galderma, Janssen, Leo Pharma, Lilly, Novartis, Pfizer, Sandoz, Sanofi, Sun Pharma, and UCB. Dr Rieder is advisor/consultant for, has received grants/honoraria from, and/or has served as a speaker for LEO Pharma, Pfizer, and Sanofi Genzyme. Drs Martinez-Cabriales, Coulombe, Aaron, Hussain, Linggonegoro, Barootes, Brandling-Bennett, Covelli, Kirkorian, Shah, Castelo-Soccio, Arkin, Heinze, Travis, Del Pozzo-Magana, Schoch, Monir, Glick, Uwakwe, Skillman, Hekman, Lethebe, and Ramien have no conflicts of interest to declare.

References

Publication types

LinkOut - more resources